NEVANAC
Pain/inflammation associated with cataract surgery
ApprovedCommercial
Key Facts
Indication
Pain/inflammation associated with cataract surgery
Phase
Approved
Status
Commercial
Company
About Harrow Health
Harrow Health is an integrated eyecare company with a mission to address unmet needs in ophthalmology through a diversified business model encompassing proprietary pharmaceuticals, non-sterile compounding, and sterile compounding. The company has achieved commercial success with several FDA-approved products and maintains a pipeline of development-stage candidates. Its strategic direction involves leveraging its ImprimisRx platform for distribution while advancing its proprietary pipeline through internal development and acquisitions.
View full company profileTherapeutic Areas
Other Pain/inflammation associated with cataract surgery Drugs
| Drug | Company | Phase |
|---|---|---|
| ILEVRO | Harrow Health | Approved |